Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody

NCT03525678

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: GSK Investigational Site New Haven, Connecticut, United States

GSK Investigational Site Atlanta, Georgia, United States

GSK Investigational Site Atlanta, Georgia, United States

GSK Investigational Site Chicago, Illinois, United States

View all 59 locations

View Trial Details

Completed

Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia

NCT05632484

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations: Hôpital Femme-mère-Enfant Bron, France

Hôpital Estaing Clermont-Ferrand, France

Hôpital St Eloi Montpellier, France

View Trial Details

Completed

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

NCT07150468

Conditions: Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma, Blood Protein Disorders, Bone Marrow Diseases, +18 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

NCT04629508

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +11 more
Locations: Tulane University New Orleans, Louisiana, United States

Rcca Md, Llc Bethesda, Maryland, United States

Midamerica Cancer Care Kansas City, Missouri, United States

New Jersey Hematology Oncology Associates Llc Brick, New Jersey, United States

View all 21 locations

View Trial Details

Completed

A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan

NCT07150793

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Novartis East Hanover, New Jersey, United States

View Trial Details

Completed

Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)

NCT03207555

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq

NCT07150286

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Al-Mustansiriyah University - college of pharmacy - clinical pharmacy department Baghdad, Baghdad Governorate, Iraq

View Trial Details

Completed

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

NCT04872621

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: Research Site Aichi, Japan

Research Site Aichi, Japan

Research Site Akita, Japan

Research Site Aomori, Japan

View all 59 locations

View Trial Details

Completed

A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.

NCT02310321

Conditions: Acute Myeloid Leukemia, FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations: Site JP81037 Anjo, Aichi-ken, Japan

Site JP00003 Nagoya, Aichi-ken, Japan

Site JP81003 Nagoya, Aichi-ken, Japan

Site JP81027 Nagoya, Aichi-ken, Japan

View all 55 locations

View Trial Details

Completed

HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease

NCT03240731

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: CHU Henri-Mondor Créteil, France

intercommunal hospital of Créteil Créteil, France

CHU La Timone Marseille, France

Hospital Necker Paris, France

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions